Hüppa põhisisu juurde
Raamatukoi
Tõde ja õigus

Epigenetic Drug Discovery

Ho Man Chan, Cheryl H Arrowsmith (toim.) · Royal Society of Chemistry · 2024

Epigenetic Drug Discovery

Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company, and a substantial number of biotechnology companies, targeting epigenetic processes to treat diseases ranging from cancer to Huntington's disease and from inflammation to sickle cell anaemia. This book aims to provide an overview of the key topics adopted in current epigenetic drug discovery programmes with a focus on major developments and new technologies. Importantly, the book incorporates case studies and outlines the key challenges and techniques employed to overcome them. The book is an ideal resource for researchers in both industry and academia with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation. The book is also an excellent introduction for postgraduates interested in the interface between epigenetics and pharmaceuticals.

Saadavus
318,00 €

Uus kasutamata raamat

Täna tellides on tarneaeg umbes 10 päeva (27.11.2026)Tellimuse täitmise aeg on umbkaudne ja sõltub nädalapäevast, millal tellimus tehakse. Reeglina ei kulu üle kahe nädala.

Tarne ja kättesaamine

Detailid

Autorid
Ho Man Chan, Cheryl H Arrowsmith (toim.)
ISBN
9781837671106
Aasta
2024
Keel
inglise
Köide
Kõva kaas
Lehekülgi
674
Teema
Meditsiin › Prekliinilised alusteadused — Pre-clinical medicine: basic sciences
Kaal
1.21 kg